MCT’s collaboration with Onxeo on HCC Phase III study in Middle East News / March 26, 2015 Onxeo has engaged MCT (Regional CRO specialized on Middle East and Africa) to expand “Relieve” phase III HCC study in 3 Middle East countries (Lebanon,…
Sickle Cell Disease Study – Site of Pr. Olayemi News / August 23, 2021 MCT is grateful to Pr. Olayemi and his team at Korle-Bu site in Ghana, for recruiting their first patients on a SCD study. No doubt…
